Health in Europe (WHO region) 168 indicators covering health for Europe (WHO region). IndicatorLatest Year10-yr change Rank ndx - number of people dying between ages x and x+n 659.38 2021 down 30.5% 10th Cases started on MDR-TB treatment 40,112 2024 down 18.4% 5th Raised fasting blood glucose (>=7.0 mmol/L) 7.3 2014 up 14.1% 9th Raised fasting blood glucose (>= 7.0 mmol/L) 8.9 2014 up 17.1% 4th Reported number of people requiring interventions against NTDs 5.96 million 2024 up 111.2% 7th Births attended by skilled health personnel 99.1% 2025 up 0.1% 1st Percentage of total deaths due to NCDs overall and percentage of 5.33 2019 down 0.5% 11th Low birth weight prevalence 7.6% 2020 down 3.8% 13th Inactivated first-dose polio vaccine (IPV1) immunization coverage 94.0% 2025 up 14.6% 2nd Low birth weight number 796 2020 down 12.6% 13th Number of current cigarette smokers, estimate 140.62 million 2030 down 12.8% 3rd Reported number of children receiving antiretroviral therapy 16,000 2025 down 11.1% 4th New or unknown treatment history cases: Pulmonary, bacteriologically 71,165 2023 down 41.6% 11th Number of children aged 6-59 months with anaemia 11,457 2019 up 3.6% 10th Prevalence of anaemia in children aged 6-59 months 20.3% 2019 down 1.5% 8th HIV-positive TB patients on ART (antiretroviral therapy) 84.0% 2024 up 44.8% 7th Treatment success rate for patients treated for MDR-TB 68.0% 2022 up 38.8% 7th Treatment success rate: HIV-positive TB cases 58 2023 up 23.4% 9th Polio vaccine: inactivated second or third-dose polio vaccine (IPVc) 89.0% 2025 — 2nd International Health Regulations core capacity scores, SPAR version 66 2025 — 1st Number of reported cases of poliomyelitis by wild poliovirus 0 2023 — 3rd Estimated number of malaria deaths 0 2024 — 7th Number of prevalent tuberculosis cases 440,000 2014 down 46.3% 9th Estimated malaria incidence 0 2024 down 100.0% 7th Estimated malaria mortality rate 0 2024 — 7th Japanese encephalitis - number of reported cases 0 2021 — 7th Number of pregnant women living with HIV who received antiretrovirals 19,000 2025 down 9.5% 4th Neonates protected at birth against neonatal tetanus (PAB) 97.0% 2022 up 7.8% 2nd Percentage of people living with HIV who know their HIV status 87 2025 up 13.0% 4th Percentage of people living with HIV who know their status receiving 77 2025 up 28.3% 5th Tuberculosis - new and relapse cases 285,789 2011 down 22.4% 9th Estimated number of pregnant women living with HIV needing 20,000 2025 down 20.0% 5th Total number of notified TB cases 329,270 2014 down 14.2% 9th Estimated number of pregnant women living with HIV 92 2025 up 8.2% 1st Smear-positive tuberculosis treatment-success rate 66.0% 2011 down 10.8% 9th Insufficiently active 82.12 2016 up 0.1% 6th Number of presumed malaria cases 0 2020 — 6th Number of indigenous malaria cases 0 2020 — 7th Number of confirmed malaria cases 144 2020 down 39.5% 7th Total number of malaria cases 144 2020 down 40.0% 7th Number of indigenous P. falciparum malaria cases 0 2020 — 7th Preterm birth rate 7.57 2020 up 1.0% 15th Preterm birth 788,364 2020 down 8.4% 14th Percentage of people living with HIV receiving treatment who have 91 2025 up 5.8% 6th Treatment success rate: XDR-TB cases 58 2022 up 123.1% 9th Confirmed cases of MDR-TB 36,772 2012 up 745.9% 2nd Number of indigenous P. vivax malaria cases 0 2020 — 7th HIV-positive TB patients on CPT (co-trimoxazole preventive therapy) 53.0% 2014 down 23.2% 9th ← Previous Page 3 of 3